| The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast … Z Mohammed, JJ Going, J Edwards, B Elsberger, JC Doughty, ... British journal of cancer 107 (5), 864-873, 2012 | 177 | 2012 |
| The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review CH Richards, Z Mohammed, T Qayyum, PG Horgan, DC McMillan Future oncology 7 (10), 1223-1235, 2011 | 154 | 2011 |
| The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer ZMA Mohammed, JJ Going, J Edwards, B Elsberger, DC McMillan British journal of cancer 109 (6), 1676-1684, 2013 | 140 | 2013 |
| The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer FJA Gujam, J Edwards, ZMA Mohammed, JJ Going, DC McMillan British journal of cancer 111 (1), 157-165, 2014 | 124 | 2014 |
| Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer ZMA Mohammed, DC McMillan, B Elsberger, JJ Going, C Orange, ... British journal of cancer 106 (2), 383-388, 2012 | 111 | 2012 |
| The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer FJA Gujam, JJ Going, J Edwards, ZMA Mohammed, DC McMillan Critical reviews in oncology/hematology 89 (2), 231-241, 2014 | 109 | 2014 |
| Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer N Ferrari, ZMA Mohammed, C Nixon, SM Mason, E Mallon, DC McMillan, ... PloS one 9 (6), e100759, 2014 | 103 | 2014 |
| The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer FJA Gujam, DC McMillan, ZMA Mohammed, J Edwards, JJ Going British journal of cancer 113 (7), 1066-1074, 2015 | 99 | 2015 |
| SIRT2: tumour suppressor or tumour promoter in operable breast cancer? LM McGlynn, S Zino, AI MacDonald, J Curle, JE Reilly, ZMA Mohammed, ... European Journal of Cancer 50 (2), 290-301, 2014 | 97 | 2014 |
| The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable … CH Richards, KM Flegg, C SD Roxburgh, JJ Going, Z Mohammed, ... British journal of cancer 106 (12), 2010-2015, 2012 | 90 | 2012 |
| The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast … ZMA Mohammed, DC McMillan, J Edwards, E Mallon, JC Doughty, ... BMC clinical pathology 13, 1-9, 2013 | 73 | 2013 |
| RUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse … L McDonald, N Ferrari, A Terry, M Bell, ZM Mohammed, C Orange, ... Disease models & mechanisms 7 (5), 525-534, 2014 | 72 | 2014 |
| Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer FJA Gujam, JJ Going, ZMA Mohammed, C Orange, J Edwards, ... BMC cancer 14, 1-11, 2014 | 61 | 2014 |
| The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative … S Dutta, JJ Going, ABC Crumley, Z Mohammed, C Orange, J Edwards, ... British journal of cancer 106 (4), 702-710, 2012 | 59 | 2012 |
| The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer ZMA Mohammed, JJ Going, J Edwards, DC McMillan Cancer treatment reviews 38 (8), 943-955, 2012 | 58 | 2012 |
| Comparison of visual and automated assessment of HER2 status and their impact on outcome in primary operable invasive ductal breast cancer ZMA Mohammed, JJ Going, DC McMillan, C Orange, E Mallon, ... Histopathology 61 (4), 675-684, 2012 | 40 | 2012 |
| The combined endocrine receptor in breast cancer, a novel approach to traditional hormone receptor interpretation and a better discriminator of outcome than ER and PR alone EJ Campbell, M Tesson, F Doogan, Z Mohammed, E Mallon, J Edwards British journal of cancer 115 (8), 967-973, 2016 | 38 | 2016 |
| Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis ZMA Mohammed, J Edwards, C Orange, E Mallon, JC Doughty, ... Histopathology 61 (2), 283-292, 2012 | 35 | 2012 |
| Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer ZMA Mohammed, C Orange, DC McMillan, E Mallon, JC Doughty, ... Human pathology 44 (8), 1688-1695, 2013 | 19 | 2013 |
| Loss of signal transducer and activator of transcription 1 is associated with prostate cancer recurrence S Hatziieremia, Z Mohammed, P McCall, JM Willder, AK Roseweir, ... Molecular carcinogenesis 55 (11), 1667-1677, 2016 | 16 | 2016 |
Joanne EdwardsProfessor of Translational Pathology, University of GlasgowVerified email at glasgow.ac.uk
